BTK mutations detected in a cohort of patients with disease progression during BTKi treatment
| . | Number of patients carrying the mutations . | P . | ||
|---|---|---|---|---|
| Ibrutinib-treated patients (n = 24) . | Zanubrutinib-treated patients (n =13) . | Total . | ||
| Cys481 codon mutations | 24 | 10 | 34 | .03 |
| Leu528Trp | 1 | 7 | 8 | .001 |
| . | Number of patients carrying the mutations . | P . | ||
|---|---|---|---|---|
| Ibrutinib-treated patients (n = 24) . | Zanubrutinib-treated patients (n =13) . | Total . | ||
| Cys481 codon mutations | 24 | 10 | 34 | .03 |
| Leu528Trp | 1 | 7 | 8 | .001 |